They may be involved in the manifestation of ovarian cancer, as previously confirmed in borderline ovarian cancer [51], and this may explain the high expression of the marker CD133 in different cancers, including the ovarian tumours found by other studies [37,38,39,40]. The gene discussed is PROM1; the disease is ovarian carcinoma.